"Warren Buffett is addicted to buybacks and dividends. I want more than that. They have to make acquisitions," said Cramer, portfolio manager of TheStreet's Action Alerts PLUS and host of CNBC's "Mad Money."
Cramer suggested that IBM buy ClickSoftware Technologies (CKSW) and CyberArk (CYBR - Get Report) . Cramer made the comments while answering viewers' questions from social media from the floor of the New York Stock Exchange Tuesday.
Cramer also discussed a number of health care and biotechnology stocks, saying that investors should buy Allergan (AGN - Get Report) , Biogen (BIIB - Get Report) and Gilead (GILD - Get Report) . Cramer also said he prefers Allergan over Valeant (VRX) and said he's staying away from Amicus Therapeutics (FOLD - Get Report) and almost all of the small biotech companies. He said small biotechs are under year-end selling pressure.
Cramer also gave his opinions on some financial related names, including E*Trade (ETFC - Get Report) and Toronto-Dominion (TD - Get Report) . Cramer said he likes TD more than E*Trade because its yield is better, but he prefers Wells Fargo (WFC - Get Report) in the financial space.
Finally, Cramer was asked about Facebook (FB - Get Report) , which Cramer said is an "up" stock, along with Amazon (AMZN - Get Report) , Netflix (NFLX - Get Report) and Alphabet (GOOG - Get Report) (GOOGL - Get Report) , formerly known as Google.
Cramer answers viewers' questions in a daily segment with TheStreetTV. Send your questions to him on his Facebook page, or on Twitter (TWTR - Get Report) , @JimCramer, and send questions with the hashtag #CramerQ.